Publications

Genes & development

Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis.

15-05-2012

Breast cancer research and treatment

Association of the germline TP53 R72P and MDM2 SNP309 variants with breast cancer survival in specific breast tumor subgroups.

01-11-2011

Nature communications

Selective inhibition of microRNA accessibility by RBM38 is required for p53 activity.

25-10-2011

BMC cancer

BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutations.

30-11-2010

Clinical cancer research : an official journal of the American Association for Cancer Research

Integration of DNA copy number alterations and prognostic gene expression signatures in breast cancer patients.

15-01-2010

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Mucinous and neuroendocrine breast carcinomas are transcriptionally distinct from invasive ductal carcinomas of no special type.

01-11-2009

Breast cancer research and treatment

Prediction of BRCA1-association in hereditary non-BRCA1/2 breast carcinomas with array-CGH.

01-08-2009

Breast cancer research : BCR

EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer.

23-12-2008

Breast cancer research : BCR

A comprehensive analysis of prognostic signatures reveals the high predictive capacity of the proliferation, immune response and RNA splicing modules in breast cancer.

19-11-2008

The Journal of pathology

Refinement of breast cancer classification by molecular characterization of histological special types.

01-10-2008

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primary.

20-09-2008

Breast cancer research : BCR

Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas.

04-10-2007

Cancer cell

A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer.

01-10-2007

Experimental lung research

Lung tumor location and lymphocyte infiltration in mice are genetically determined.

01-06-2005

Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis.

Association of the germline TP53 R72P and MDM2 SNP309 variants with breast cancer survival in specific breast tumor subgroups.

Selective inhibition of microRNA accessibility by RBM38 is required for p53 activity.

BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutations.

Integration of DNA copy number alterations and prognostic gene expression signatures in breast cancer patients.

Mucinous and neuroendocrine breast carcinomas are transcriptionally distinct from invasive ductal carcinomas of no special type.

Prediction of BRCA1-association in hereditary non-BRCA1/2 breast carcinomas with array-CGH.

EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer.

A comprehensive analysis of prognostic signatures reveals the high predictive capacity of the proliferation, immune response and RNA splicing modules in breast cancer.

Refinement of breast cancer classification by molecular characterization of histological special types.

Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primary.

Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas.

A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer.

Lung tumor location and lymphocyte infiltration in mice are genetically determined.

This site uses cookies